SZSE:002693 (China)
Â
Class A
Â¥
5.23
(+3.77%)
Apr 29
Business Description
Hainan Shuangcheng Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001K63
Share Class Description:
SZSE:002693: Class ACompare
Compare
Traded in other countries / regions
002693.China IPO Date
2012-08-08Description
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.55 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -59.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.13 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.3 | |||||
| 3-Year EBITDA Growth Rate | -11.7 | |||||
| 3-Year EPS without NRI Growth Rate | 6.5 | |||||
| 3-Year Book Growth Rate | -2.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.72 | |||||
| 9-Day RSI | 42.79 | |||||
| 14-Day RSI | 40.87 | |||||
| 6-1 Month Momentum % | -6.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.33 | |||||
| Days Inventory | 339.42 | |||||
| Days Sales Outstanding | 29.3 | |||||
| Days Payable | 72.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 0.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.12 | |||||
| Operating Margin % | -10.98 | |||||
| Net Margin % | 4.25 | |||||
| FCF Margin % | -13.89 | |||||
| ROE % | 2.13 | |||||
| ROA % | 1.23 | |||||
| ROIC % | -2.72 | |||||
| ROC (Joel Greenblatt) % | -0.6 | |||||
| ROCE % | -0.45 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 201.15 | |||||
| PE Ratio without NRI | 209.2 | |||||
| PS Ratio | 8.55 | |||||
| PB Ratio | 4.15 | |||||
| Price-to-Tangible-Book | 6.23 | |||||
| Price-to-Operating-Cash-Flow | 5230 | |||||
| EV-to-EBIT | -780.5 | |||||
| EV-to-EBITDA | -780.5 | |||||
| EV-to-Revenue | 8.39 | |||||
| EV-to-FCF | -60.41 | |||||
| Price-to-Projected-FCF | 7.07 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 7.58 | |||||
| Earnings Yield (Greenblatt) % | -0.13 | |||||
| FCF Yield % | -1.65 | |||||
| Forward Rate of Return (Yacktman) % | -9.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hainan Shuangcheng Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 259.139 | ||
| EPS (TTM) (Â¥) | 0.026 | ||
| Beta | -0.26 | ||
| Volatility % | 38.91 | ||
| 14-Day RSI | 40.87 | ||
| 14-Day ATR (Â¥) | 0.289416 | ||
| 20-Day SMA (Â¥) | 5.395 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (Â¥) | 3.67 - 9.72 | ||
| Shares Outstanding (Mil) | 416.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hainan Shuangcheng Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hainan Shuangcheng Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hainan Shuangcheng Pharmaceuticals Co Ltd Frequently Asked Questions
What is Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)'s stock price today?
The current price of SZSE:002693 is ¥5.23. The 52 week high of SZSE:002693 is ¥9.72 and 52 week low is ¥3.67.
When is next earnings date of Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)?
The next earnings date of Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) is .
Does Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) pay dividends? If so, how much?
Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers